The value of progression-free survival as a treatment endpoint among patients with advanced cancer: A systematic review and qualitative assessment of the literature
JAMA Dec 19, 2019
Raphael MJ, Robinson A, Booth CM, et al. - In this systematic review and qualitative assessment of the literature of 17 studies comprising 3,646 individuals, experts summarized and qualitatively evaluated studies assessing whether people with advanced cancer understood and valued PFS. For the endpoint of PFS, the current literature assessing peoples’ understanding, preferences, and significance was seriously limited through the heterogeneity of methods, attribute choice, and definitions used to describe PFS to people.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries